Latest News
Valion Bio, Inc.
- Form 8K Valion Bio Inc For: 22 October By Investing.com
- Form 8K Valion Bio Inc For: 22 October By Investing.com
- Valion Bio Sets 30-Day Agenda for Pipeline, Velocity Bioworks and Shareholder Value
- Valion Bio interim CEO outlines strategic priorities By Investing.com
- Valion Bio interim CEO outlines strategic priorities By Investing.com
- Form S-3 Valion Bio Inc For: 16 October By Investing.com
- Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
- Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers Initial Feasibility Milestone
- Valion Bio develops oral form of radiation countermeasure Entolimod
- Valion Bio, Inc. Seeks Acquisitions
- Valion Bio Raises $50,000 in Private Sale of Series B Preferred and Warrants to 3i
- Valion Bio, Inc. (VBIO) Appoints Thomas H. Jensen as Board Chair
Headlines from the last 30 days, linking to the original publishers. See all market news →